Frequently bought together

Brand : GYNERA

GYNERA TAB 21/TAB

17.65

Sku : I-002731
Key features
Gynera 21 Coated Tablet 30,75 µg is a combined oral contraceptive containing ethinylestradiol 30 µg and gestodene 75 µg. It works by suppressing ovulation, thickening cervical mucus, and causing endometrial changes that make pregnancy less likely. It is used for oral contraception. This product is supplied as coated tablets in a pack of 21 tablets.
- Brand: GYNERA
- Active Ingredient: ETHINYLESTRADIOL 30µg, GESTODENE 75µg
- Strength: 30,75µg
- Dosage Form: Coated tablet
- Pack Size: 21 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Contraceptive
- Pharmacological Group: Hormonal Contraceptives
- Drug Class: Combined oral contraceptive (COC): ethinylestradiol (estrogen) + gestodene (third‑generation progestin), monophasic 21‑day formulation.
- Manufacturer: BAYER AG
- Country of Origin: Germany
- SFDA Registration No.: 0206222126
- Shelf Life: 24 months
- Storage: do not store above 30°c
- Hormone Type: Combined
- Method: Oral

Frequently bought together

Description

Specification

Indications

Approved Uses

Oral contraception

Dosage & Administration

Dosing by Condition

Contraception: 1 tablet orally daily for 21 days, then 7 days tablet‑free; repeat with the next pack starting on day 8.

Maintenance Dose

One tablet daily for 21 days followed by 7 tablet-free days

Maximum Dose

1 tablet orally once daily (ethinylestradiol 30 µg/gestodene 75 µg) as per the verified strength and oral dosage form.

Side Effects

Common Side Effects

Nausea, headache, breast tenderness or pain, breakthrough bleeding or spotting, mood changes, decreased libido, weight changes, contact lens intolerance

Side Effect Frequency

Common (≥1% to <10%): nausea, abdominal pain, headache, breast pain/tenderness, mood changes, weight change, and irregular uterine bleeding/spotting; Rare/very rare: venous and arterial thromboembolic events.

Special Populations

Pregnancy

Contraindicated

Pharmacology

Mechanism of Action

Suppresses ovulation via inhibition of gonadotropins (FSH/LH), thickens cervical mucus to impede sperm penetration, and induces endometrial changes that reduce the likelihood of implantation.